Congenica
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $88M
Investors
- 14
About Congenica
, is a digital health company enabling genomic medicine for the research used for analysis and interpretation of genomic data. In September 2025, SeqOne SAS, a portfolio company of Elaia Partners, Omnes Capital, Merieux Equity Partners, Supernova Invest, and Irdi Capital Investissement, agreed to acquire Congenica Ltd., Downing, IDO Investments, Legal and General Group, Puhua Capital, Tencent Investment, Xeraya Capital, and and QVentures. The company's clinical decision support and analysis platform, Sapientia, offers analysis, interpretation, and analysis of the entire human genome data. Congenica's platform provides researchers with genome analysis, enabling them to interpret next-generation sequencing data, maximize cash throughput, and improve health outcomes. The company provides analysis using automation and AI technology, without the requirement of manual intervention. Additionally, the company provides Congenica Express Database and the variant prioritization tool, Exomiser, which allows variant prioritization in the Congenica NGS analysis platform to improve diagnostic yields by an average of 30%, as well as Congenica Neuro and Congenica Prenatal specialist modules.1 to reduce time spent on genetic analysis as well as interpretational and reporting services.
Who invested in Congenica
14 investors across 7 rounds
See all investors in Congenica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Mar 3, 2021
Amount
$2.6M
Investors
Series C
Nov 9, 2020
Amount
$51M
Investors
Series B
Apr 30, 2019
Amount
$17M
Investors
Series B
Apr 24, 2017
Amount
$2.6M
Investors
Series B
Feb 13, 2017
Amount
$10M
Investors
Series A
Apr 1, 2015
Amount
$3.3M
Investors
Seed
Nov 26, 2014
Amount
$0.8M
Investors
Questions about Congenica
Who invested in Congenica?
Congenica has 14 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Congenica raised?
Congenica has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Congenica last raise money?
Congenica's most recent round on record is a Series C, in Mar 2021.
What does Congenica do?
, is a digital health company enabling genomic medicine for the research used for analysis and interpretation of genomic data.
Where is Congenica headquartered?
Congenica is headquartered in Cambridge, UK.
Which VCs invest in companies like Congenica?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Congenica's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Congenica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.